Patents by Inventor Newton Muchugu WAHOME

Newton Muchugu WAHOME has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GBS FERRITIN NANOPARTICLES
    Publication number: 20230303637
    Abstract: Polypeptides capable of self-assembling into a nanoparticle, and nanoparticles made up of such polypeptides.
    Type: Application
    Filed: June 11, 2021
    Publication date: September 28, 2023
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Matthew James BOTTOMLEY, Newton Muchugu WAHOME
  • DOCK TAG SYSTEM
    Publication number: 20230250142
    Abstract: Pairs of peptides capable of forming spontaneous covalent bonds, and their uses, such as in forming fusion proteins.
    Type: Application
    Filed: June 11, 2021
    Publication date: August 10, 2023
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Matthew James BOTTOMLEY, Roberta COZZI, Newton Muchugu WAHOME
  • MODIFIED BETACORONAVIRUS SPIKE PROTEINS
    Publication number: 20230234992
    Abstract: Betacoronavirus Spike proteins, or fragments thereof, including substitution mutations designed to increase stability, decrease the risk of antibody dependent enhancement, or both; and that are useful in, for example, immunogenic compositions.
    Type: Application
    Filed: June 4, 2021
    Publication date: July 27, 2023
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Marco BIANCUCCI, Joel David KARPIAK, Jason Paul LALIBERTE, Anna Ulrika LOWEGARD, Enrico MALITO, Newton Muchugu WAHOME
  • MODIFIED HUMAN CYTOMEGALOVIRUS PROTEINS
    Publication number: 20230201334
    Abstract: Modified HCMV gB proteins in a non-post-fusogenic conformation, compositions comprising such proteins, and uses thereof.
    Type: Application
    Filed: July 22, 2020
    Publication date: June 29, 2023
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Marco BIANCUCCI, Sumana CHANDRAMOULI, Newton Muchugu WAHOME
  • THERAPEUTIC VIRAL VACCINE
    Publication number: 20220273789
    Abstract: The present invention relates to viral Fc receptor or immunogenic fragments thereof for treating a viral infection in a subject and, in particular, a herpes vims infection. The present invention also relates to a heterodimer comprising or consisting of an Fc receptor from a HSV vims or an immunogenic fragment thereof and a binding partner from said HSV vims or a fragment thereof, for use in therapy.
    Type: Application
    Filed: July 20, 2020
    Publication date: September 1, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Normand BLAIS, Cindy CASTADO, Johann MOLS, Lionel SACCONNAY, Marie TOUSSAINT, Newton Muchugu WAHOME, Giulietta MARUGGI